Health Catalyst (HCAT) Short-term Investments (2018 - 2026)

Health Catalyst's Short-term Investments history runs 9 years deep, the most recent figure standing at $49.0 million for Q1 2026.

• Quarterly Short-term Investments changed N/A year-over-year to $49.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $49.0 million (changed N/A YoY) and the FY2025 annual result came in at $44.9 million, down 68.45% from the prior year.
• Short-term Investments was $49.0 million for Q1 2026 at Health Catalyst, up from $44.9 million in the prior quarter.
• Across five years, Short-term Investments topped out at $255.9 million in Q3 2022 and bottomed at $44.9 million in Q4 2025.
• A 5-year average of $156.1 million and a median of $176.9 million in 2023 frame the typical range for Short-term Investments.
• Annual changes were most pronounced in 2022 — Short-term Investments soared 292.58% — and 2024, when it slumped 76.68%.
• Health Catalyst's Short-term Investments stood at $247.2 million in 2022, then slipped by 14.45% to $211.5 million in 2023, then slumped by 32.68% to $142.4 million in 2024, then slumped by 68.45% to $44.9 million in 2025, then advanced by 9.0% to $49.0 million in 2026.
• Business Quant data shows HCAT's Short-term Investments at $49.0 million in Q1 2026, $44.9 million in Q4 2025, and $51.2 million in Q3 2025.